Bertoli Mitchell is delighted to have advised Cancer Research UK in the sale of its prestigious British Journal of Cancer to Springer Nature. 

Cancer Research UK is the world’s largest independent cancer research charity. British Journal of Cancer is a leading international journal in cancer research with nearly 75 years of heritage.

Bertoli Mitchell acted as the exclusive financial advisor to Cancer Research UK (CRUK) and worked closely with CRUK through all stages on the way to execution. Matt Kaiser, CRUK’s Head of Discovery Research, commented: “We received exceptional and dedicated support from Bertoli Mitchell throughout the project, and the care and thoughtfulness in approach was hugely valued. The team was always on hand, acting in the very best interests of CRUK as their client, to provide the specialist knowledge and experience that was critical to its successful delivery.” 

This transaction further enhances Bertoli Mitchell’s track record in the journal sector with more than 20 transactions completed. Recently closed transactions (2020) include the sale of BJOG: An International Journal of Obstetrics and Gynaecology to Wiley, in which Bertoli Mitchell represented the Royal College of Obstetricians and Gynaecologists; the sale of Current Oncology by our client Multimed (Canada) to MDPI; and the sale of Metallomics by our client the Royal Society of Chemistry to Oxford University Press.

Bertoli Mitchell transaction team 

Natalina Bertoli (Managing Partner)
Philip Shaw (Senior Associate)
Paul Mitton (Senior Associate)

If you would like more information about our role in this transaction, please contact Natalina Bertoli on +44 (0)20 3866 7140, or email her at nb@bertolimitchell.co.uk.

About Bertoli Mitchell

Bertoli Mitchell is an independent advisory firm focused on serving clients in publishing and information services. We help our clients to sell whole companies, shares, corporate divisions, or selected assets. We also advise on strategic alliances and joint ventures, business and asset valuations, and strategy. Since 1994 we have advised on over 150 transactions, as well as completing over 50 strategy advisory assignments.